Norway· NO-ID_0ECFF9A9-71C3-4C62-BD51-6782BCF8B059
Gemcitabin SUN
A gemcitabine product containing gemcitabine, registered in Norway by Sun Pharmaceutical Ind. Europe BV. The same ATC class is registered in 17 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Gemcitabine is registered in 17 of 19 countries.
Countries holding a registration under ATC L01BC05 (gemcitabine), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 10 of them publish a price we can compare per daily dose
Gemcitabine · ATC L01BC05
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of gemcitabine costs, country by country.
Normalised to the WHO defined daily dose (0.2 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Gemcitabine · price per daily dose (0.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$27.60
The record
At a glance
FEST (Norway)- Active substance
- Gemcitabine
- Manufacturer
- Sun Pharmaceutical Ind. Europe BV
- Country
- Norway (NO)
- ATC code
- L01BC05
- ATC class
- Gemcitabine
- Defined daily dose
- 0.2 g, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- October 2, 2026
Packs & prices · 13
6 priced- no_merkevare_idID_0ECFF9A9-71C3-4C62-BD51-6782BCF8B059
- no_varenummer061608180NOK 3181.5
- no_varenummer514179220NOK 3880.4
- no_varenummer109326200NOK 3530.9
- no_varenummer550648120NOK 2133.1
- no_varenummer186162140NOK 2482.5
- no_varenummer193166160NOK 2832
- gtin8718531944022
- gtin8718531944565
- gtin8718531944299
- gtin8718531943216
- gtin8718531946576
- gtin8718531943483
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
370 interactions on record for gemcitabine.
Graded by severity as the source publishes them — 33 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Gemcitabine · interactions on record
370 records
- 33 severe
- 114 moderate
- 19 minor
- 204 info
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- CladribineL01BB04severe
- PexidartinibL01EX15severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Gemcitabine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumGemcitabine Sun 10 mg/mlSun Pharmaceutical Industries Europe
- SpainGEMCITABINA SUN 10 MG/ML SOLUCION PARA PERFUSIONSun Pharmaceutical Industries (Europe) B.V.
- FinlandGemcitabin SunSun Pharmaceutical Industries Europe B.V.
- PolandGemcitabine SUNSun Pharmaceutical Industries Europe B.V.
- SwedenGemcitabin SUN 10 mg/ml Infusionsvätska, lösningSun Pharmaceutical Industries Europe B.V.
- United KingdomGemcitabine 1.2g/120ml infusion bagsSun Pharma UK Ltd
- United StatesAVGEMSIAvyxa Pharma, LLC
- NetherlandsGemcitabine 1000 mg PCH, poeder voor oplossing voor infusiePharmachemie B.V.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Gemcitabin Accord, Gemcitabin Ebewe
- Belgium · Gemcitabin Sandoz, Gemcitabin Sun
- Bulgaria · Гемсол, Гемцитабин Акорд
- Cyprus · Gemcitabine Accord, Gemnil
- Czechia · Gemcitabin Ebewe, Gemcitabin Sun
- Germany · Bendacitabin, Gemci-Cell
- Denmark · Gemcitabin "sandoz", Gemcitabin Accord
- Estonia · Gemcitabine Accord, Gemcitabine Kabi
- Spain · Gemcitabina Accord, Gemcitabina Aurovitas Spain
- Finland · Gemcitabin Accord, Gemcitabin Sandoz
- France · Gemcitabine Accord, Gemcitabine Arrow
- United Kingdom (Northern Ireland) · Gemcitabine Accord Healthcare, Gemcitabine Ennogen Ip
- Greece · Demozar, Gemcipen
- Croatia · Gemcitabin Accord, Gemcitabin Sandoz
- Hungary · Gemcitabin Kabi, Gemcitabine Accord
- Ireland · Gemcitabine, Gemcitabine Accord Healthcare
- Iceland · Gemcitabin Wh, Gemkabi
- Italy · Gemcitabina Accord, Gemcitabina Aurobindo Pharma Italia
- Lithuania · Gemcitabine Accord, Gemcitabine Kabi
- Luxembourg · Gemcitabine Eg, Gemcitabine Eugia
- Latvia · Gemcitabine Accord, Gemcitabine Kabi
- Malta · Gemcitabine Pfizer Hellas, Gemnil
- Netherlands · Gemcitabine Accord, Gemcitabine Fresenius Kabi
- Poland · Gemcitabine Kabi, Gemcitabinum Accord
- Portugal · Gemcit, Gemcitabina Accord
- Romania · Gemcitabină Accord, Gemcitabina Kabi
- Sweden · Gemcitabin Sandoz, Gemcitabin Sun
- Slovenia · Gemcitabin Accord, Gemcitabin Kabi
- Slovakia · Gemcitabín Sun, Gemcitabine Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4393f6b9-f9f9-4e57-8456-8973d4b9d396 GET /v1/drugs/4393f6b9-f9f9-4e57-8456-8973d4b9d396?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Infusjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Gemcitabin",
"merkevare_id": "ID_0ECFF9A9-71C3-4C62-BD51-6782BCF8B059",
"name_form_strength": "Gemcitabin SUN inf, oppl 10 mg/ml",
"prescription_group": "C"
}See everything about gemcitabine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.